These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8555280)

  • 41. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).
    Fischer B; Cruz MF; Patra J; Rehm J
    J Subst Abuse Treat; 2008 Apr; 34(3):340-6. PubMed ID: 17614236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients.
    Schreiber S; Peles E; Adelson M
    Drug Alcohol Depend; 2008 Jan; 92(1-3):79-85. PubMed ID: 17706374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid measurement of plasma methadone in a clinical setting using florescence polarization immunoassay.
    Kell MJ; Techman T
    J Addict Dis; 1996; 15(2):69-83. PubMed ID: 8704002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence.
    Karow A; Verthein U; Pukrop R; Reimer J; Haasen C; Krausz M; Schäfer I
    Subst Use Misuse; 2011; 46(6):705-15. PubMed ID: 21047149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities.
    Rosenblum A; Joseph H; Fong C; Kipnis S; Cleland C; Portenoy RK
    JAMA; 2003 May; 289(18):2370-8. PubMed ID: 12746360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of psychiatric disorder in a methadone maintenance population.
    Callaly T; Trauer T; Munro L; Whelan G
    Aust N Z J Psychiatry; 2001 Oct; 35(5):601-5. PubMed ID: 11551274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Drug dependent patients in the methadone maintenance program: evaluation in primary care of psychosocial and organic severity].
    Ruz Franzi I; González-Saiz F; Ruiz Avila F
    Aten Primaria; 1998 Apr; 21(6):384-8. PubMed ID: 9633138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program.
    Pani PP; Trogu E; Contu P; Agus A; Gessa GL
    Drug Alcohol Depend; 1997 Nov; 48(2):119-26. PubMed ID: 9363411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Good and bad times for treating cigarette smoking in drug treatment.
    Richter KP
    J Psychoactive Drugs; 2006 Sep; 38(3):311-5. PubMed ID: 17165374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Methadone substitution--a scientific review in the context of out-patient therapy in Germany].
    Weinmann S; Kunstmann W; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2004 Nov; 98(8):673-82. PubMed ID: 15646730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abstinence following detoxification and methadone maintenance treatment.
    Cushman P
    Am J Med; 1978 Jul; 65(1):46-52. PubMed ID: 686001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK.
    Newman RG
    J Clin Pharm Ther; 2007 Jun; 32(3):325; author reply 325-6. PubMed ID: 17489886
    [No Abstract]   [Full Text] [Related]  

  • 53. 'Idiopathic' intestinal failure--the importance of identifying and treating primary psychopathology.
    Bourke J; Soldan J; Silk DB; Aziz Q; Libby GW
    Neurogastroenterol Motil; 2012 Mar; 24(3):242-51. PubMed ID: 22188396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Jungian typology and opiate dependency.
    Roszell DK; Chaney EF; Blaes P
    J Psychoactive Drugs; 1983; 15(3):199-206. PubMed ID: 6631591
    [No Abstract]   [Full Text] [Related]  

  • 55. Fifty opiate addicts treated with methadone blockade. Eight-year follow up.
    Dalton MS; Duncan DW
    Med J Aust; 1979 Mar; 1(5):153-4. PubMed ID: 449754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of a constraint satisfaction network model for the evaluation of the methadone treatments of drug addicts.
    Massini G; Shabtay L
    Subst Use Misuse; 1998 Feb; 33(3):625-56. PubMed ID: 9533733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug treatment outcomes for persons on waiting lists.
    Chun J; Guydish JR; Silber E; Gleghorn A
    Am J Drug Alcohol Abuse; 2008; 34(5):526-33. PubMed ID: 18618338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimanic, antidepressant, and antipanic effects of opiates: clinical, neuroanatomical, and biochemical evidence.
    Gold MS; Pottash AC; Sweeney D; Martin D; Extein I
    Ann N Y Acad Sci; 1982; 398():140-50. PubMed ID: 6961853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relapse prevention: Using sound to reduce the probability of recidivism and suffering following detoxification.
    Sewak R; Spielholz NI
    Med Hypotheses; 2018 Sep; 118():84-91. PubMed ID: 30037621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study.
    Rounsaville BJ; Kosten TR; Weissman MM; Kleber HD
    Arch Gen Psychiatry; 1986 Aug; 43(8):739-45. PubMed ID: 3729668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.